Summary
Inozyme Pharma Inc
Founded in 2017
Description
Breakthrough Solutions at the Speed of Science.
Strengths
- Revenue generated per employee is greater than industry average
- Since Inozyme Pharma Inc was founded, the company has grown faster than the industry average
Weaknesses
- Inozyme Pharma Inc has a very small market share in their industry
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Variance of revenue growth is more than the industry average
Annual Revenue
Inozyme Pharma Inc's annual revenue
$14690000
Based on Kona Equity data
-
Revenue per employee
$293800
-
Variance of revenue growth
5.05
-
Annual revenue growth since founding
$1350333
-
Revenue growth rate from first known quarter to current
-31.3%
Employee Count
50 employees
-
Employee growth rate from first known quarter to current
-59.3%
Executives
Catherine Nester
Vice President, Physician, Patient Strategies
c**@inozyme.comHenric Bjarke
Senior VP & Chief Operating Officer
h**@inozyme.comAxel Bolte
CEO
a**@inozyme.comSoojin Kim
Senior VP & Chief Technical Operations Officer
s**@inozyme.comArialle Weinstein
Senior Accountant
a**@inozyme.comDaniel Ortiz
Senior Director, Research
d**@inozyme.comDaniel Michaels
Manager, Laboratory
d**@inozyme.comJean-Christophe Francois
Associate Director, Supply Chain
j**@inozyme.comApril Sheedy
Senior Accountant
a**@inozyme.comSanjay Subramanian
Chief Financial Officer
s**@inozyme.comMallory Bissett
Senior Director, Clinical Operations
m**@inozyme.comKurt Gunter
Chief Medical Officer
k**@inozyme.comDeborah Wenkert
Senior Vice President, Chief Marketing Officer
d**@inozyme.comDamon Banks
Vice President, Legal Affairs & Secretary
d**@inozyme.comSean Cullen
Vice President, Manufacturing
s**@inozyme.comJennifer Howe
Program Manager, Preclinical
j**@inozyme.comLeontia Burke
Vice President, Clinical Operations
l**@inozyme.comGayle Gironda
Senior VP, Human Resources
g**@inozyme.comDamon Banksvice
Vice President, Legal Affairs & Secretary
d**@inozyme.comCaitlin Decandia
Manager, Contracts
c**@inozyme.comGus Khursigara
Clinical Operations Vice President, Medical Affairs
g**@inozyme.comShanthini Jeyarajah
Analytical Development Director, Quality Control
s**@inozyme.comBrian Luque
Director, Investor Relations
b**@inozyme.comDebra Taylor
Controller
d**@inozyme.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Magenta Therapeutics, Inc.
magentatx.com- Founded in 2015
- Location: Cambridge, MA
- Annual Revenue: $15.9M
- Employees: 86
- Magenta Therapeutics is a clinical-stage biotech developing therapeutics to curative power of stem cell transplants to more patients
Visterra , Inc.
visterrainc.com- Founded in 2007
- Location: Waltham, Massachusetts
- Annual Revenue: $18.9M
- Employees: 53
- Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...
Fulcrum Therapeutics, Inc.
fulcrumtx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $17.0M
- Employees: 104
- Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.
Leap Therapeutics
leaptx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $1.1M
- Employees: 36
- Leap Therapeutics, Inc. (Nasdaq: LPTX) is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer patients. Their most advanced clinical candidate, DKN 01, is a humanized monoclonal antibody...
Orphazyme
orphazyme.com- Founded in 2009
- Location: Copenhagen', None
- Annual Revenue: $5.1M
- Employees: 62
- Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients wit...
Navitor Pharmaceuticals , Inc.
navitorpharma.com- Founded in 2010
- Location: Cambridge, MA
- Annual Revenue: $3.9M
- Employees: 16
- Navitor Pharmaceuticals, Inc. is a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling pathways. The company's proprietary drug discovery platform targets mTORC1, which plays a key role in protein synthesis and...
Key Information
- Name: Inozyme Pharma Inc
- Category: Biotechnology
- SIC: 28; 283
- NAICS: 32541; 5417
See similar companies
-
By City Boston Biotechnology in Boston Small Biotechnology in Boston Mid-size Biotechnology in Boston
-
By State MA Small companies in MA Biotechnology in MA Small Biotechnology in MA Mid-size Biotechnology in MA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology G Score of 2
-
Firmographic data G Score of 2 Founded in 2017 SIC: 28 SIC: 283 NAICS: 32541 NAICS: 5417 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
Inozyme Pharma Inc's headquarters are located at 280 Summer St., Fl. 5 Boston, MA 02210.
Inozyme Pharma Inc's official website is inozyme.com
Inozyme Pharma Inc's annual revenue is $14.7 M.
Inozyme Pharma Inc's SIC: 28; 283
Inozyme Pharma Inc's NAICS: 32541; 5417.
Inozyme Pharma Inc has 50 employees
Inozyme Pharma Inc is in the industry of Biotechnology.
